ERS 2026 Guidelines for PAH Do Not Exist
There are no European Respiratory Society (ERS) guidelines for pulmonary arterial hypertension published in 2026. The most recent joint ESC/ERS guidelines for pulmonary hypertension were published in 2022, not 2026 1.
Current Guidelines Available
The 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension represent the most up-to-date official guidance 2. These updated the previous 2015 ESC/ERS guidelines and incorporated recommendations from the 6th World Symposium on Pulmonary Hypertension.
Key Changes in the 2022 Guidelines:
- New hemodynamic definition: Mean pulmonary artery pressure (mPAP) threshold lowered from ≥25 mmHg to >20 mmHg to define PH 2
- Pulmonary vascular resistance (PVR) threshold of >2 Wood units now required for pre-capillary PH classification 2
- Reintroduction of exercise-induced PH as a diagnostic entity 2, 3
- Refined 4-strata risk stratification at follow-up, splitting the intermediate-risk group into intermediate-low and intermediate-high 4
- Updated treatment algorithms emphasizing upfront combination therapy for most PAH patients 5, 6
Where to Access the Guidelines
The official 2022 ESC/ERS guidelines are published in both the European Heart Journal and the European Respiratory Journal 1. They are freely available on the ESC website at: http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines 1.
Important Caveat
If you are looking for the most recent guidance, ensure you are referencing the 2022 guidelines, not searching for non-existent 2026 guidelines. The 7th World Symposium on Pulmonary Hypertension held in Barcelona in June 2024 has provided updated recommendations that may inform future guideline revisions 5, but these have not yet been incorporated into official ESC/ERS guidelines.